Активы Изменить Дата
AbbVie USD 135.12B 1.35B 2026-06
Aena EUR 19.71B 911.52M 2026-09
Alcon AG USD 31.1B 521M 2026-06
Almirall EUR 2.37B 29.97M 2026-06
Amarin USD 634.08M 9.72M 2026-09
Amgen USD 95.64B 3.14B 2026-06
AstraZeneca USD 115.83B 1.82B 2026-06
Bayer EUR 107.29B 659M 2026-06
Biogen USD 32.05B 32.5M 2026-09
BMW EUR 270.62B 4.66B 2026-03
Bristol-Myers Squibb USD 88.77B 1.14B 2026-09
Eli Lilly USD 148.07B 5.79B 2026-09
Essilor EUR 65.06B 1.16B 2026-06
Fresenius EUR 41.84B 526M 2026-06
Fresenius Medical Care EUR 31.29B 174.35M 2026-06
Genmab DKK 12.52B 139M 2026-06
Gilead Sciences USD 51.41B 2.05B 2026-09
GlaxoSmithKline GBP 71.7B 9.96B 2026-09
GRIFOLS EUR 20.09B 12M 2026-06
Hikma Pharmaceutical USD 5.67B 117M 2025-12
J&J USD 197.42B 3.64B 2026-09
Lakefront Biotherapeutics EUR 3.35B 21.24M 2026-06
Lonza CHF 18.97B 164M 2025-12
Mercedes-Benz AG EUR 256.42B 3.3B 2026-09
Merck EUR 52.69B 383M 2026-06
Merck USD 129.8B 1.12B 2026-06
Novartis USD 122.03B 3.5B 2026-06
Novo Nordisk DKK 594.94B 35.72B 2026-06
Orion EUR 2.03B 160.3M 2026-09
Pfizer USD 201.13B 6.49B 2026-06
Philips EUR 26.7B 565M 2026-06
Recordati EUR 5.37B 33.76M 2026-06
Regeneron Pharmaceuticals USD 44.41B 2.67B 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 129.06B 1.04B 2026-06
Sanofi EUR 128.02B 1.22B 2026-03
SAP EUR 76.34B 727M 2026-09
UCB EUR 18.16B 971M 2025-12
Vinci EUR 134.87B 1.8B 2026-06
Volkswagen EUR 661.41B 7.93B 2026-09